What the BIEL Vagus Nerve Patent (Pending) Covers
Post# of 8896
(Total Views: 220)
Posted On: 11/09/2025 12:32:54 AM
What the BIEL Vagus Nerve Patent (Pending) Covers
Non-invasive vagus nerve stimulation: The patent outlines systems and devices that stimulate the vagus nerve without surgery or implants.
Immune modulation: It targets chronic inflammation by altering immune responses, based on promising results from a double-blind canine study.
Electromagnetic pulse technology: Builds on Biel’s existing products like ActiPatch and RecoveryRx, which use pulsed electromagnetic fields (PEMF) for pain relief.
Optimization Opportunities
Integrate with wearable tech: Embed the vagus stimulation system into smart wearables for continuous, adaptive therapy.
Expand clinical applications: Use in treating arthritis, depression, diabetes, and cardiovascular conditions—all linked to inflammation.
Veterinary medicine: Extend use to animal care, as the patent’s efficacy was demonstrated in canine trials.
Data-driven personalization: Combine with AI to tailor stimulation patterns based on user biometrics and feedback.
Regulatory and IP strategy: Fast-track FDA clearance and global patent filings to secure market leadership.
Strategic Relevance
Drug-free alternative: Offers a scalable solution for patients seeking non-pharmaceutical options.
Chronic care innovation: Aligns with healthcare trends toward remote, preventive, and personalized care.
Market differentiation: Strengthens BIEL's position in the wearable medical device space with proprietary tech.
Non-invasive vagus nerve stimulation: The patent outlines systems and devices that stimulate the vagus nerve without surgery or implants.
Immune modulation: It targets chronic inflammation by altering immune responses, based on promising results from a double-blind canine study.
Electromagnetic pulse technology: Builds on Biel’s existing products like ActiPatch and RecoveryRx, which use pulsed electromagnetic fields (PEMF) for pain relief.
Optimization Opportunities
Integrate with wearable tech: Embed the vagus stimulation system into smart wearables for continuous, adaptive therapy.
Expand clinical applications: Use in treating arthritis, depression, diabetes, and cardiovascular conditions—all linked to inflammation.
Veterinary medicine: Extend use to animal care, as the patent’s efficacy was demonstrated in canine trials.
Data-driven personalization: Combine with AI to tailor stimulation patterns based on user biometrics and feedback.
Regulatory and IP strategy: Fast-track FDA clearance and global patent filings to secure market leadership.
Strategic Relevance
Drug-free alternative: Offers a scalable solution for patients seeking non-pharmaceutical options.
Chronic care innovation: Aligns with healthcare trends toward remote, preventive, and personalized care.
Market differentiation: Strengthens BIEL's position in the wearable medical device space with proprietary tech.
(2)
(0)